DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Health Care Sector Update for 12/19/2014: CRME, TEVA, OREX

Is a Biosimilar (Generic) Top Cancer Drug for You?

Pfizer, Inc. Invests in Growth... Literally

Pfizer, Inc. pays $275 million upfront for commercialization rights to Opko Health Inc.'s promising human growth hormone drug.

Pfizer Ponies Up to Develop Long-acting Growth Hormone

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

UPDATE: Sterne Agee Upgrades Teva Pharmaceutical

Mylan Among First to Launch Generic Celebrex - Analyst Blog

Teva Pharmaceutical TEVA) Stock Up Today on Higher 2015 Profit Estimate

Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic Competition

Merck-Cubist Deal On Despite Patent Setback, Shares Fall - Analyst Blog

See More Articles...